Equities

PuraPharm Corp Ltd

PuraPharm Corp Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)0.67
  • Today's Change0.00 / 0.00%
  • Shares traded22.50k
  • 1 Year change-37.96%
  • Beta0.4971
Data delayed at least 15 minutes, as of Sep 20 2024 08:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments207660
Total Receivables, Net113156300
Total Inventory176191200
Prepaid expenses9.792624
Other current assets, total313728
Total current assets350486611
Property, plant & equipment, net397431492
Goodwill, net182121
Intangibles, net353841
Long term investments262425
Note receivable - long term------
Other long term assets------
Total assets8441,0161,206
LIABILITIES
Accounts payable146138141
Accrued expenses181926
Notes payable/short-term debt161213172
Current portion long-term debt/capital leases161216248
Other current liabilities, total858077
Total current liabilities571665665
Total long term debt10375111
Total debt425503532
Deferred income tax1.743.022.61
Minority interest------
Other liabilities, total151525
Total liabilities691758804
SHAREHOLDERS EQUITY
Common stock307307306
Additional paid-in capital222222221
Retained earnings (accumulated deficit)(381)(279)(158)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total5.648.9032
Total equity153258402
Total liabilities & shareholders' equity8441,0161,206
Total common shares outstanding396396395
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.